White label ELPA - ClinicalTrials.eu

Study on the Safety and Tolerability of Cariprazine for Treating Schizophrenia in Adolescents Aged 13-17

Not recruiting

3 1 1 1
Investigated diseases:
- Schizophrenia
Investigated drugs:
- Cariprazine
- Cariprazine Hydrochloride
Study on the Effects of Etavopivat for Patients Aged 12-65 with Sickle Cell Disease

Not recruiting

4 1
Investigated diseases:
- Sickle cell disease
Investigated drugs:
- Etavopivat
Study of Lecanemab (BAN2401) Treatment in People with Early Alzheimer’s Disease: Testing Safety and Effectiveness Over 18 Months

Not recruiting

3 1 1
Investigated diseases:
- Prodromal Alzheimer’s disease
- Dementia Alzheimer’s type
Investigated drugs:
- Lecanemab
Study on the Effectiveness and Safety of Barzolvolimab in Adults with Active Eosinophilic Esophagitis

Not recruiting

2 1 1
Investigated diseases:
- Eosinophilic oesophagitis
Investigated drugs:
- Barzolvolimab
- Epinephrine
Study of Sacituzumab Govitecan, Pembrolizumab, and a Platinum Drug Combination for Advanced Non-Small Cell Lung Cancer Patients Without Genomic Alterations

Not recruiting

2 1 1 1
Investigated diseases:
- Non-small cell lung cancer
Investigated drugs:
Study on Vemurafenib for Patients with Advanced Cancers with BRAF Gene Changes

Not recruiting

2 1 1 1
Investigated diseases:
- Neoplasm
Investigated drugs:
- Vemurafenib
Study on the Safety and Effectiveness of ABSK021 for Patients with Tenosynovial Giant Cell Tumor

Not recruiting

3 1
Investigated diseases:
- Giant cell tumour of tendon sheath
Investigated drugs:
- Absk021 Hydrochloride Hydrate
Study on the Safety and Effectiveness of Lutetium (177Lu) Vipivotide Tetraxetan for Patients with Recurrent or Metastatic Adenoid Cystic Carcinoma

Not recruiting

2 1 1 1
Investigated diseases:
- Adenoid cystic carcinoma of salivary gland
Investigated drugs:
- Lutetium (177Lu) Vipivotide Tetraxetan
Study on the Safety and Effectiveness of LT3001 for Patients with Acute Ischemic Stroke

Not recruiting

2 1
Investigated diseases:
- Ischaemic stroke
Investigated drugs:
- Lt3001
Study on Trastuzumab and Pertuzumab for Patients with HER2-Positive Breast Cancer Using a Response-Adapted Strategy

Not recruiting

2 1 1 1
Investigated diseases:
- HER2 positive breast cancer
Investigated drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies